Human Metabolome Technologies - Cambridge, Massachusetts 02139

Human Metabolome Technologies is categorized under Commercial Biotechnical Research in Cambridge, MA .

Business Name: Human Metabolome Technologies
Contact Person: Tsutomu Hoshiba, President
Address: 1 Kendall Square, Cambridge, Massachusetts 02139
Phone Number: (617) 871-9940
Website Address: humanmetabolome.com
Annual Revenue (USD): Unknown
Founding Year: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 5417114
Share This Business:
Related Businesses: Infinity Discovery Inc - Cambridge, MA 02139
Babyboost Inc - Cambridge, MA 02139
Visolis Inc - Cambridge, MA 02139
Volvox Biologic Inc - Cambridge, MA 02139
Manus Biosynthesis - Cambridge, MA 02139
Epi Zyme Inc - Cambridge, MA 02139
Mersana Therapeutics Inc - Cambridge, MA 02139
Dna Medicine Institute Inc - Cambridge, MA 02139
Galenea Corp - Cambridge, MA 02139
Bluebird Bio Inc - Cambridge, MA 02139
Ariad Corp - Cambridge, MA 02139
Alantos Pharmaceuticals Inc - Cambridge, MA 02139
Rana Therapeutics Inc - Cambridge, MA 02139
Mindsjungle Inc - Cambridge, MA 02139
Warp Drive Bio LLC - Cambridge, MA 02139

The company Human Metabolome Technologies provides B2B services in the form of Commercial Biotechnical Research from its single location in Massachusetts. 1 to 4 employees work for Human Metabolome Technologies, and the business now earns Unknown per annum.

Human Metabolome Technologies was launched in 2013 and is classified under SIC code and category 8731 , and NAICS number and grouping 5417114 . To contact Human Metabolome Technologies, please call Tsutomu Hoshiba, President with the phone number (617) 871-9940 or visit its single location at 1 Kendall Square in Cambridge, Massachusetts 02139.

The location of the single location can also be found using the coordinates 42.3631,-71.1033. Read more details about this business on the webpage humanmetabolome.com or follow the company’s social media accounts, on Twitter and on Facebook.